Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   HIV post-treatment controllers have distinct immunological and virological features
  2. Etemad, Behzad; Sun, Xiaoming; Li, Yijia; Melberg, Meghan; Moisi, Daniela; Gottlieb, Rachel; Ahmed, Hayat; Aga, Evgenia; Bosch, Ronald J; Acosta, Edward P; Yuki,Yuko; Martin, Maureen P; Carrington,Mary; Gandhi, Rajesh T; Jacobson, Jeffrey M; Volberding, Paul; Connick, Elizabeth; Mitsuyasu, Ronald; Frank, Ian; Saag, Michael; Eron, Joseph J; Skiest, Daniel; Margolis, David M; Havlir, Diane; Schooley, Robert T; Lederman, Michael M; Yu, Xu G; Li, Jonathan Z
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Mar 14; 120(11): e2218960120.
  1. 2.   Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption
  2. Lau, Chuen-Yen; Adan, Matthew A; Earhart, Jessica; Seamon, Cassie; Nguyen,Thuy; Savramis, Ariana; Adams, Lindsey; Zipparo, Mary-Elizabeth; Madeen,Erin; Huik, Kristi; Grossman, Zehava; Chimukangara, Benjamin; Wulan, Wahyu Nawang; Millo, Corina; Nath, Avindra; Smith, Bryan R; Ortega-Villa, Ana M; Proschan, Michael; Wood, Bradford J; Hammoud, Dima A; Maldarelli,Frank
  3. Frontiers in Medicine. 2022, Aug; 9: 979756.
  1. 3.   Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir
  2. Immonen,Taina; Fennessey,Christine; Lipkey,Leslie; Thorpe, Abigail; Del Prete,Greg; Lifson,Jeffrey; Davenport, Miles P.; Keele,Brandon
  3. PLOS PATHOGENS. 2021, Jun; 17(6):
  1. 4.   HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs
  2. De Scheerder, Marie-Angélique; Vrancken, Bram; Dellicour, Simon; Schlub, Timothy; Lee, Eunok; Shao,Wei; Rutsaert, Sofie; Verhofstede, Chris; Kerre, Tessa; Malfait, Thomas; Hemelsoet, Dimitri; Coppens, Marc; Dhondt, Annemieke; De Looze, Danny; Vermassen, Frank; Lemey, Philippe; Palmer, Sarah; Vandekerckhove, Linos
  3. Cell host & microbe. 2019, SEP 11; 26(3): 347-+.
  1. 5.   Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.
  2. Gay, Cynthia L; DeBenedette, Mark A; Tcherepanova, Irina Y; Gamble, Alicia; Lewis, Whitney E; Cope, Anna B; Kuruc, JoAnn D; McGee, Kara S; Kearney, Mary; Coffin, John M; Archin, Nancie M; Hicks, Charles B; Eron, Joseph J; Nicolette, Charles A; Margolis, David M
  3. AIDS research and human retroviruses. 2018, JAN; 34(1, SI): 111-122.
  1. 6.   Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy
  2. Shimada, M.; Wang, H. B.; Kondo, A.; Xu, X. P.; Yoshida, A.; Shinoda, K.; Ura, T.; Mizuguchi, H.; Klinman, D.; Luo, J. L.; Bai, H.
  3. Gene Therapy. 2009 16(2): 218-228.
  1. 7.   Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA+IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques
  2. Halwani, R.; Boyer, J. D.; Yassine-Diab, B.; Haddad, E. K.; Robinson, T. M.; Kumar, S.; Parkinson, R.; Wu, L.; Sidbu, M. K.; Phillipson-Weiner, R.; Pavlakis, G. N.; Felber, B. K.; Lewis, M. G.; Shen, A.; Siliciano, R. F.; Weiner, D. B.; Sekaly, R. P.
  3. Journal of Immunology. 2008 180(12): 7969-7979.
  1. 8.   Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
  2. Hare, C. B.; Mellors, J.; Krambrink, A.; Su, Z. H.; Skiest, D.; Margolis, D. M.; Patel, S. S.; Barnas, D.; Frenkel, L.; Coombs, R. W.; Aweeka, F.; Morse, G. D.; Haas, D. W.; Boltz, V.; Palmer, S.; Coffin, J.; Havlir, D. V.
  3. Clinical Infectious Diseases. 2008 47(3): 421-424.
  1. 9.   The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness
  2. Healey, L. M.; Hahn, B. K.; Rehm, C. A.; Adelsberger, J.; Qin, J.; Follmann, D. A.; Tavel, J.; Kovacs, J. A.; Sereti, I.; Davey, R. T.
  3. Journal of Interferon and Cytokine Research. 2008 28(7): 455-461.
  1. 10.   Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency
  2. Halvas, E. K.; Aldrovandi, G. M.; Balfe, P.; Beck, I. A.; Boltz, V. F.; Coffin, J. M.; Frenkel, L. M.; Hazelwood, J. D.; Johnson, V. A.; Kearney, M.; Kovacs, A.; Kuritzkes, D. R.; Metzner, K. J.; Nissley, D. V.; Nowicki, M.; Palmer, S.; Ziermann, R.; Zhao, R. Y.; Jennings, C. L.; Bremer, J.; Brambilla, D.; Mellors, J
  3. Journal of Clinical Microbiology. 2006, Jul; 44(7): 2612-2614.
  1. 11.   Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
  2. Palmer, S.; Boltz, V.; Maldarelli, F.; Kearney, M.; Halvas, E. K.; Rock, D.; Falloon, J.; Davey, R. T.; Dewar, R. L.; Metcalf, J. A.; Mellors, J. W.; Coffin, J. M.
  3. Aids. 2006, Mar; 20(5): 701-710.
  1. 12.   Anti-interleukin-12 antibody for active Crohn's disease
  2. Mannon, P. J.; Fuss, I. J.; Mayer, L.; Elson, C. O.; Sandborn, W. J.; Present, D.; Dolin, B.; Goodman, N.; Groden, C.; Hornung, R. L.; Quezado, M.; Neurath, M. F.; Salfeld, J.; Veldman, G. M.; Schwertschlag, U.; Strober, W.
  3. New England Journal of Medicine. 2004, NOV 11; 351(20): 2069-2079.
  1. 13.   Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
  2. Dybul, M.; Chun, T. W.; Yoder, C.; Hidalgo, B.; Belson, M.; Hertogs, K.; Larder, B.; Dewar, R. L.; Fox, C. H.; Hallahan, C. W.; Justement, J. S.; Migueles, S. A.; Metcalf, J. A.; Davey, R. T.; Daucher, M.; Pandya, P.; Baseler, M.; Ward, D. J.; Fauci, A. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(26): 15161-15166.
  1. 14.   Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
  2. Park, You Jeong; Etemad, Behzad; Ahmed, Hayat; Naranbhai, Vivek; Aga, Evgenia; Bosch, Ronald J; Mellors, John W; Kuritzkes, Daniel R; Para, Michael; Gandhi, Rajesh T; Carrington, Mary; Li, Jonathan Z
  3. Pathogens & immunity. 2017 2(3): 431-445.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel